BioSpace News Archive

Venture Firm Wellington Partners Launches $237 Million Life Science Fund

The fund plans to build a portfolio of about 15 to 20 companies, with a focus on novel biotechnology platforms, new therapeutics and medical devices, as well as diagnostics and digital medicine.

July 31, 2019
·
2 min read
·
Mark Terry
Deals

Esperion to Report Second Quarter 2019 Financial Results August 8, 2019

Esperion announced it will report second quarter 2019 financial results on August 8, 2019 before the U.S. financial markets open.

July 31, 2019
·
5 min read
FDA

Merck’s Keytruda Has Been Approved for 20+ Indications, With the Latest Being for Esophageal Cancer

The U.S. Food and Drug Administration approved the anti-PD-1 therapy as a monotherapy for patients with recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus whose tumors express PD-L1 with disease progression after one or more previous lines of systemic therapy.

July 31, 2019
·
3 min read
·
Mark Terry
Business

Charles River Labs to Launch Bay Area CRADL Facility in 2020

Charles River Labs will open its CRADL facility in South San Francisco in January 2020 in order to provide flexible, turnkey vivarium rental space for startups.

July 31, 2019
·
4 min read
·
Mark Terry and Alex Keown
Business

Alexandria Real Estate Equities Plans Another Boston Life Sciences Lab Facility

The site “represents a strategic opportunity to expand Alexandria’s unparalleled, world-class” life science development in the Boston area, said Peter Moglia, co-chief executive officer and co-chief investment officer of Alexandria.

July 31, 2019
·
2 min read
·
Mark Terry
Business

Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer

Arvinas, Inc., a biotechnology company creating a new class of drugs based on targeted protein degradation, announced the appointment of Ronald Peck, M.D. to the newly created position of Chief Medical Officer.

July 31, 2019
·
5 min read
Drug Development

Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis

Atlantic Healthcare plc, a specialist pharmaceutical company focused on acquiring, developing and commercializing therapeutics that address unmet patient needs and rare diseases, announced the results of the Phase 3 trial of Camligo™ for orphan-designated pouchitis.

July 31, 2019
·
5 min read
Policy

HHS Announces Possible Roadmap for Importing Drugs from Canada

As reported yesterday, the Trump administration is evaluating proposals to allow consumers to buy drugs legally from Canada. Today, their efforts became more official as the U.S. Department of Health and Human Services announced their intentions.

July 31, 2019
·
4 min read
·
Mark Terry
Wellington Partners raises EUR 210 million life science fund

Wellington Partners, a leading European venture capital firm investing in early- and growth-stage life science companies, today announced the final close of its fifth-generation fund Wellington Partners Life Science Fund V (WPLS-V).

July 31, 2019
·
4 min read
Business

Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease using Clinical Artificial Intelligence

First major drug development agreement signed by Sensyne Health since IPO with potential for expansion

July 31, 2019
·
3 min read